Mean platelet volume predicts prognosis in patients with diffuse large B‐cell lymphoma
Shujuan Zhou(Shanghai Medical College of Fudan University), Siqian Wang(Shandong University), Zhouyi Zheng(Wenzhou Medical University), Bin Liang(Chinese PLA General Hospital), Fang Fang(Jinshan Hospital of Fudan University), Yu Zhang(Second Affiliated Hospital of Dalian Medical University), Kang Yu(Wenzhou Medical University), Yi Chen(Wenzhou Medical University), Jianhua Feng(Wenzhou Medical University), Yongyong Ma(Wenzhou Medical University), Liyuan Tang(Wenzhou Medical University), Lan Sun(Wenzhou Medical University), Yifen Shi(First Affiliated Hospital of Wenzhou Medical University), Zhijian Shen(Wenzhou Medical University), Songfu Jiang(Wenzhou Medical University)
Cited by 19
Related Papers
Telomere Length and All-Cause Mortality: A Meta-analysis
|Ageing Research Reviews|2018|332
Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
|Journal of Clinical Oncology|2009|245
Phase II Study of the Halichondrin B Analog Eribulin Mesylate in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane, and Capecitabine
|Journal of Clinical Oncology|2010|217
Metabolic Profile and Long-Term Risk of Depression, Anxiety, and Stress-Related Disorders
|JAMA Network Open|2024|139
Mediterranean diet and depression: a population-based cohort study
|International Journal of Behavioral Nutrition and Physical Activity|2021|138